This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 44/2/163    most recent 01.HYP.0000134790.02026.e4v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by José, G. S. Articles by Zalba, G. Search for Related Content PubMed PubMed Citation Articles by José, G. S. Articles by Zalba, G. Related Collections Hypertension - basic studies Clinical Studies Genetics of cardiovascular disease Mechanism of atherosclerosis/growth factors

(Hypertension. 2004;44:163.)
© 2004 American Heart Association, Inc.

Scientific Contributions

Functional Effect of the p22^phox –930^A/G Polymorphism on p22^phox Expression and NADPH Oxidase Activity in Hypertension

Gorka San José; María U. Moreno; Sara Oliván; Oscar Beloqui; Ana Fortuño; Javier Díez; Guillermo Zalba

From the Area of Cardiovascular Pathophysiology (G.S.J., M.U.M., S.O., A.F., J.D. G.Z.), Centre for Applied Medical Research; Department of Internal Medicine (O.B.); and Department of Cardiology and Cardiovascular Surgery (J.D.), University Clinic, School of Medicine, University of Navarra, Pamplona, Spain.

Correspondence to Dr Guillermo Zalba, Fisiopatología Cardiovascular, Facultad de Medicina, Irunlarrea 1, 31008 Pamplona, Spain. E-mail gzalba{at}unav.es

Oxidative stress induced by superoxide is implicated in hypertension. NADPH oxidase is the main source of superoxide in phagocytic and vascular cells, and the p22^phox subunit is involved in NADPH oxidase activation. Recently we reported an association of –930^A/G polymorphism in the human p22^phox gene promoter with hypertension. This study was designed to investigate the functional role of this polymorphism in hypertension. We thus investigated the relationships between the –930^A/G polymorphism and p22^phox expression and NADPH oxidase–mediated superoxide production in phagocytic cells from 70 patients with essential hypertension and 70 normotensive controls. Genotyping of the polymorphism was performed by restriction fragment length polymorphism. NADPH oxidase activity was determined by chemiluminescence assays, and p22^phox mRNA and protein expression was measured by Northern and Western blotting, respectively. Compared with hypertensive subjects with the AA/AG genotype, hypertensive subjects with the GG genotype exhibited increased (P<0.05) phagocytic p22^phox mRNA (1.26±0.06 arbitrary unit [AU] versus 0.99±0.03 AU) and protein levels (0.58±0.05 AU versus 0.34±0.04 AU) and enhanced NADPH oxidase activity (1998±181 counts/s versus 1322±112 counts/s). No differences in these parameters were observed among genotypes in normotensive cells. Transfection experiments on vascular smooth muscle cells showed that the A-to-G substitution of this polymorphism produced an increased reporter gene expression in hypertensive cells. Nitric oxide production, as assessed by measurement of serum nitric oxide metabolites, was lower in GG hypertensive subjects than in AA/AG hypertensive subjects. In conclusion, these results suggest that hypertensive subjects carrying the GG genotype of the p22^phox –930^A/G polymorphism are highly exposed to NADPH oxidase-mediated oxidative stress.

Key Words: hypertension, arterial • oxidative stress • polymorphism

This article has been cited by other articles:

				M. Arca, B. Conti, A. Montali, P. Pignatelli, F. Campagna, F. Barilla, G. Tanzilli, R. Verna, A. Vestri, C. Gaudio, et al. C242T Polymorphism of NADPH Oxidase p22phox and Recurrence of Cardiovascular Events in Coronary Artery Disease Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): 752 - 757. [Abstract] [Full Text] [PDF]

				L. Hering, F. Herse, S. Verlohren, J.-K. Park, M. Wellner, F. Qadri, R. Pijnenborg, A. C. Staff, B. Huppertz, D. N. Muller, et al. Trophoblasts Reduce the Vascular Smooth Muscle Cell Proatherogenic Response Hypertension, February 1, 2008; 51(2): 554 - 559. [Abstract] [Full Text] [PDF]

				K. Tsukimori, H. Nakano, and N. Wake Difference in Neutrophil Superoxide Generation During Pregnancy Between Preeclampsia and Essential Hypertension Hypertension, June 1, 2007; 49(6): 1436 - 1441. [Abstract] [Full Text] [PDF]

				K. Bedard and K.-H. Krause The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology Physiol Rev, January 1, 2007; 87(1): 245 - 313. [Abstract] [Full Text] [PDF]

				A. Fortuno, G. San Jose, M. U. Moreno, O. Beloqui, J. Diez, and G. Zalba Phagocytic NADPH Oxidase Overactivity Underlies Oxidative Stress in Metabolic Syndrome Diabetes, January 1, 2006; 55(1): 209 - 215. [Abstract] [Full Text] [PDF]

				J. A. Leopold and J. Loscalzo Oxidative Enzymopathies and Vascular Disease Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1332 - 1340. [Abstract] [Full Text] [PDF]

				G. Zalba, O. Beloqui, G. S. Jose, M. U. Moreno, A. Fortuno, and J. Diez NADPH Oxidase-Dependent Superoxide Production Is Associated With Carotid Intima-Media Thickness in Subjects Free of Clinical Atherosclerotic Disease Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1452 - 1457. [Abstract] [Full Text] [PDF]

				R. M Touyz Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II Exp Physiol, July 1, 2005; 90(4): 449 - 455. [Abstract] [Full Text] [PDF]

				A. Fortuno, G. S. Jose, M. U Moreno, J. Diez, and G. Zalba Oxidative stress and vascular remodelling Exp Physiol, July 1, 2005; 90(4): 457 - 462. [Abstract] [Full Text] [PDF]